Article CommentaryCommentaire

Les tests pharmacogénomiques

Améliorer le recours personnalisé aux médicaments pour les patients

Catrina M. Loucks, Gabriella Groeneweg, Carl Roy, David K. Lee, Michael J. Rieder, Denis Lebel, Shinya Ito, Colin J. Ross and Bruce C. Carleton
Canadian Family Physician April 2020; 66 (4) 247-249;
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson{at}gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Respond to this article
Les tests pharmacogénomiques
Catrina M. Loucks, Gabriella Groeneweg, Carl Roy, David K. Lee, Michael J. Rieder, Denis Lebel, Shinya Ito, Colin J. Ross, Bruce C. Carleton
Canadian Family Physician Apr 2020, 66 (4) 247-249;
Twitter logo Facebook logo Mendeley logo

Jump to section

Subjects